Fluarix Tetra Description

Each 0.5 ml vaccine dose contains 15 μg haemagglutinin of each of the recommended strains.
Fluarix Tetra is an inactivated influenza vaccine (split virion), containing antigens (propagated in embryonated eggs) equivalent to the following strains: A/Sydney/5/2021 (H1N1)pdm09 - like strain (A/Sydney/5/2021, IVR-229);
A/Darwin/9/2021(H3N2) - like strain (A/Darwin/6/2021, IVR-227);
B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26);
B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, wild type).
This vaccine complies with the WHO recommended strains (Southern Hemisphere) for the season 2023.
Fluarix Tetra meets the WHO requirements for biological substances and influenza vaccines and the European Pharmacopoeia requirements for influenza vaccines.
Excipients/Inactive Ingredients: Sodium chloride, disodium phosphate dodecahydrate, potassium dihydrogen phosphate, potassium chloride, magnesium chloride hexahydrate, α-tocopheryl hydrogen succinate, polysorbate 80, octoxinol 10 and water for injections.
Hydrocortisone, gentamicin sulphate, ovalbumin, formaldehyde and sodium deoxycholate are present as residues from the manufacturing process.